Ordinary and extraordinary assembly at BioXell
(Thomson Reuters ONE) -
bioXell S.p.A / Ordinary and extraordinary assembly at BioXell processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
Milan, Italy, March 29, 2010 - BioXell S.p.A. (SIX Swiss Exchange: BXLN)
announced that at the ordinary and extraordinary shareholders' meeting held on
29 March 2010, shareholders unanimously approved:
* changes to the Articles of Association, with resolutions to reduce the
number of directors to 2 (two), to move the headquarters to Lainate, Milan,
via Colombo, 1 and to simplify the corporate governance;
* request of delisting of company's shares on SIX Swiss Stock Exchange and
cessation of external auditing requirements;
* appointment of the new Board of Directors and of Statutory Auditors;
* postponement of the approval of 2009 Statutory Financial Statements to June
24, 2010, pending a series of decisions on the future of the Company,
including its potential liquidation.
The meeting was attended by one shareholder, who represented 98.96% of the total
share capital of the Company.
For further information, please contact:
BioXell S.p.A.
Dr. Chris Tanner
Tel.: +39 02 9333 7617
Fax : +39 02 9333 7663
E-mail:Chris.Tanner(at)cosmopharmaceuticals.com
This press release can be downloaded atwww.bioxell.com
Disclaimer
This document does not constitute, or form part of, any offer to purchase or
sell any shares or other securities and neither it nor any part of it shall form
the basis of, or be relied upon in connection with any contract or commitment
whatsoever. Any decision to tender shares must be based on the official offer
documents. This document does also not constitute a pre-announcement or an
offering prospectus pursuant to Swiss laws or any other laws.
This press release does not constitute or form part, or all, of any offer or
invitation to sell or issue, or any solicitation of any offer to purchase or
subscribe for, any securities, nor shall part, or all, of these materials or
their distribution form the basis of, or be relied on in connection with, any
contract or investment decision in relation to any securities. This press
release contains forward-looking statements based on the currently held beliefs
and assumptions of the management of BioXell, which are expressed in good faith
and, in their opinion, reasonable. Forward-looking statements involve known and
unknown risks, uncertainties and other factors, which may cause the actual
results, financial condition, performance, or achievements of BioXell, or
industry results, to differ materially from the results, financial condition,
performance or achievements expressed or implied by such forward-looking
statements. Given these risks, uncertainties and other factors, recipients of
this document are cautioned not to place undue reliance on these forward-looking
statements. BioXell disclaims any obligation to update these forward-looking
statements to reflect future events or developments.
[HUG#1398982]
--- End of Message ---
bioXell S.p.A
via Olgettina 58 Milan Italy
WKN: A0J3MW;ISIN: IT0004069933 ;
Listed: Open Market (Freiverkehr) in Frankfurter Wertpapierbörse,
Freiverkehr in Bayerische Börse München;
English version PDF: http://hugin.info/133681/R/1398982/354553.pdf
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.03.2010 - 13:04 Uhr
Sprache: Deutsch
News-ID 1012135
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Milan
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 197 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ordinary and extraordinary assembly at BioXell
"
steht unter der journalistisch-redaktionellen Verantwortung von
bioXell S.p.A (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
